Introduction {#sec1-1}
============

Hyperlipidemia is a well-known risk factor for atherosclerosis.\[[@ref1]\] Atherosclerosis is one of the main causes of death and disability worldwide.\[[@ref2]\] The modern anti-hyperlipidemic agents such as statins are widely used for reducing cardiovascular risk; however, they are not devoid of potentially serious side effects.\[[@ref3]\] For developing novel hypolipidemic agents, it has been focused on alternative natural products because of their great effectiveness, safety, and well-tolerability.\[[@ref4][@ref5]\]

*Teucrium polium* L. (Labiatae) is a medicinal plant and a rich source of different bioactive compounds.\[[@ref5]\] Studies have established various pharmacological effects such as antioxidant, antidiabetic, antispasmodic, antihypertensive, cardiotonic, antinociceptive, antigastric ulcer, anti-inflammatory, and cytotoxic properties for *T. polium*.\[[@ref6][@ref7][@ref8][@ref9][@ref10][@ref11]\] Plants belonging to the genus Teucrium are popular for their hypoglycemic and hypolipidemic activities.\[[@ref12]\] Some studies have shown the lipid-lowering activity of aqueous extract of *T. polium* in hyperlipidemic rats.\[[@ref13][@ref14]\] To obtain the most efficient herbal fraction for isolation and identification of the metabolites responsible for hypolipidemic activity, the present study aimed to investigate the effect of different fractions of *T. polium* on serum lipid profile in dexamethasone (Dex)-induced hyperlipidemic rats.

Methods {#sec1-2}
=======

Chemicals {#sec2-1}
---------

The biochemical kits for evaluation of lipid profile, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were purchased from Pars Azmoon Co. (Iran). Folin--Ciocalteu reagent and all other chemicals were purchased from Merck Co., (Germany).

Plant material and fractionation {#sec2-2}
--------------------------------

Aerial parts of *T. polium* were collected from Shahrekord in Chaharmahal and Bakhtiari Province, Iran in May 2015. It was identified by a botanist (Dr. Mustafa Ghanadian, Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran) and its voucher specimen (no. 2718) was deposited at the Herbarium of Isfahan School of Pharmacy and Pharmaceutical Sciences.

For preparation of hydroalcoholic extract, the air-dried plant material (3 kg) was soaked in percolation tank using ethanol: water (70:30) for 3 days and then extracted with a flow of 2 mL/min for 5 days. It was filtered and concentrated by rotary evaporator at 45°C to yield a green viscous residue (257 g). This extract was dissolved in methanol: water (70:30) and partitioned with hexane in a separation funnel to give a biphasic solution. Upper solution (hexanoic part) rich in chlorophyll and fats was discarded and methanolic part was concentrated, suspended in water, and then successively partitioned between equal volumes of chloroform and butanol to give chloroform, butanol, and aqueous fractions. Each fraction was evaporated under vacuum condition and kept in refrigerator at −20°C until use.

Total phenolic assay {#sec2-3}
--------------------

Determination of total phenolic content was performed using colorimetric Folin--Ciocalteu procedure.\[[@ref15]\] Briefly, each plant sample (20 μL) was mixed with diluted Folin--Ciocalteu reagent and sodium carbonate (20%). After 120 min, absorbance was read at 765 nm by a ultraviolet-visible spectrophotometer. Total phenols' amount was estimated using a standard curve of gallic acid and was expressed as milligram of gallic acid equivalents (GAEs)/100 mg of the dried plant extract in three independent experiments.

Animals {#sec2-4}
-------

Male Wistar albino rats weighing 200--220 g were obtained from the animal house of Isfahan School of Pharmacy and Pharmaceutical Sciences. Animals had free access to tap water and standard rat pellet and were kept under standard laboratory condition including a 12 h light/12 h dark cycle and 20°C ± 2°C temperature. The experiment was conducted according to the international guidelines for laboratory animal use and care.

Experimental protocol {#sec2-5}
---------------------

Rats were randomly divided into 15 groups of 6 rats in each. To induce hyperlipidemia, animals received subcutaneously (s.c.) injection of Dex (10 mg/kg/day) for 7 days.\[[@ref16]\] In the test groups, rats received Dex and simultaneously treated orally with 50, 100, or 150 mg/kg of *T. polium* hydroalcoholic extract or different fractions using an intragastric tube.\[[@ref13]\] Negative control group received daily injection of saline (1 mL/kg, s.c.) and orally administration of the vehicle (carboxymethyl cellulose 1% in water). Atorvastatin (40 mg/kg, orally) was administered as a reference treatment in positive control group. At the end of the experiment on day 8, blood samples of overnight fasted rats were collected from retroorbital plexus with heparinized capillary tubes under light ether anesthesia. Serum was collected for biochemical analysis and animals were sacrificed by an overdose of anesthetic.

Biochemical analysis {#sec2-6}
--------------------

For estimation of hepatic marker enzymes (ALT, AST) and lipid profile including triglycerides, total cholesterol, and high-density lipoprotein-cholesterol (HDL-C), the respective biochemical kits were used while low-density lipoprotein-cholesterol (LDL-C) and atherogenic index were calculated using the following formulas: LDL-C = cholesterol − (triglyceride/5) − HDL-C and atherogenic index = (total cholesterol − HDL-C)/HDL-C.\[[@ref14]\] All experiments were repeated at least three times.

Statistical analysis {#sec2-7}
--------------------

The results were reported as mean ± standard error of mean. For statistical evaluation, one-way analysis of variance followed by Tukey *post hoc* test was performed using SPSS software version 18.0 (SPSS Ltd., Quarry Bay, Hong Kong). *P* \< 0.05 was considered statistically significant.

Results {#sec1-3}
=======

Total phenolic content {#sec2-8}
----------------------

*T. polium* was standardized based on its polyphenoic contents. The hydroalcoholic extract, chloroform, butanol, and aqueous fractions were contained %7.53 ± 0.55, %2.64 ± 0.47, %11.51 ± 0.46, and %13.48 ± 0.33 GAE (mg/100 mg), respectively.

Effect on triglyceride levels {#sec2-9}
-----------------------------

Administration of Dex resulted in a significant increase in serum triglyceride level (*P* \< 0.001). Atorvastatin and chloroform fraction (at all doses) significantly reduced triglyceride level compared to Dex control group (47.8% and 60.2%, respectively). However, there was no significant difference between 3 doses of chloroform fraction. Hydroalcoholic extract and butanol fraction at the dose of 50 mg/kg (*P* \< 0.001) and aqueous fraction at the dose of 150 mg/kg (*P* \< 0.05) were found to be effective in decreasing triglyceride level (27.0%, 43.9% and 19.9%, respectively). Maximum reduction of 60.2% was observed for chloroform fraction at the dose of 150 mg/kg \[[Figure 1](#F1){ref-type="fig"}\]. The *post hoc* analysis of results also showed significant differences between the chloroform fraction at the dose of 150 mg/kg with other fractions at their highest dose (*P* \< 0.001).

![Effect of different fractions of *Teucrium polium* on serum triglyceride and cholesterol levels in dexamethasone-induced hyperlipidemic rats, ^\#\#\#^*P* \< 0.001 versus normal, \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001 versus dexamethasone control group](IJPVM-9-30-g001){#F1}

Effect on cholesterol levels {#sec2-10}
----------------------------

Dex caused a significant elevation in cholesterol level (*P* \< 0.001). As shown in [Figure 1](#F1){ref-type="fig"}, atorvastatin significantly reduced cholesterol level (21.3%). Hydroalcoholic extract reduced cholesterol concentration at all doses; however, it was more effective at the lowest dose (29.0%). Aqueous and chloroform fractions showed lowering effect at the dose of 150 mg/kg (21.2% and 17.96% reduction, respectively). More analysis of groups also revealed significant differences between the hydroalcoholic extract at the dose of 50 mg/kg with other fractions at their lowest dose (*P* \< 0.001). No cholesterol-lowering effect was observed for butanol fraction.

Effect on high-density lipoprotein levels {#sec2-11}
-----------------------------------------

Significant decrease in HDL level was observed in Dex-induced hyperlipidemic rats (*P* \< 0.05). Treatment with atorvastatin, hydroalcoholic extract, and butanol fraction (at the highest dose) significantly increased HDL level (37%, 28% and 33%, respectively). Administration of doses of 100 and 150 mg/kg from aqueous fraction was also effective in increasing HDL (28% and 30%, respectively). However, maximum elevation of 35% in HDL level was found for chloroform fraction at the highest dose \[[Figure 2](#F2){ref-type="fig"}\]. Multiple analyses showed no significant difference between various doses of different fractions.

![Effect of different fractions of *Teucrium polium* on high-density lipoprotein and low-density lipoprotein levels in dexamethasone-induced hyperlipidemic rats, ^\#^*P* \< 0.05 and ^\#\#\#^*P* \< 0.001 versus normal, \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001 versus dexamethasone group](IJPVM-9-30-g002){#F2}

Effect on low-density lipoprotein levels {#sec2-12}
----------------------------------------

In Dex-induced hyperlipidemic rats, LDL level significantly increased compared to normal rats (*P* \< 0.001). Treatment with atorvastatin and aqueous fraction (at highest dose) significantly reduced LDL level (30.1% and 50.0%, respectively). Maximum reduction of 72.9% was observed for hydroalcoholic extract. However, no lowering effect was observed on LDL concentration for butanol and chloroform fractions \[[Figure 2](#F2){ref-type="fig"}\]. The *post hoc* analysis of results also exhibited significant differences between various doses of hydroalcoholic extract with different doses of other fractions (*P* \< 0.001) except for aqueous fraction at its highest dose (*P* = 0.85).

Effect on atherogenic index {#sec2-13}
---------------------------

All treatments significantly (*P* \< 0.001) decreased atherogenic index as a noteworthy predictor of atherosclerosis in hyperlipidemic rats \[[Figure 3](#F3){ref-type="fig"}\]. More analysis of groups also showed significant differences between the hydroalcoholic extract at the dose of 50 mg/kg with other fractions at their lowest dose (*P* \< 0.01). However, there was a significant difference at the dose of 100 mg/kg (*P* \< 0.001) and 150 mg/kg (*P* \< 0.01) only with butanol fraction.

![Effect of different fractions of *Teucrium polium* on atherogenic index in dexamethasone-induced hyperlipidemic rats, ^\#\#\#^*P* \< 0.001 versus normal group, \*\**P* \< 0.01, and \*\*\**P* \< 0.001 versus dexamethasone control group](IJPVM-9-30-g003){#F3}

Effect on alanine aminotransferase and aspartate aminotransferase levels {#sec2-14}
------------------------------------------------------------------------

As exhibited in [Figure 4](#F4){ref-type="fig"}, administration of hydroalcoholic extract of *T. polium* and its fractions at all doses significantly increased serum level of ALT and AST in hyperlipidemic rats in a dose-dependent manner (*P* \< 0.001). The less toxic effect on serum level of ALT was observed for hydroalcoholic extract, especially at the dose of 150 mg/kg compared with aqueous and chloroform fractions (*P* \< 0.001). The most toxic effect on AST level was found for chloroform fraction at all doses compared with other fractions (*P* \< 0.01 at the dose of 50 mg/kg and *P* \< 0.001 at higher doses).

![Effect of different fractions of *Teucrium polium* on serum aspartate aminotransferase and alanine aminotransferase levels in dexamethasone-induced hyperlipidemic rats, ^\#\#\#^*P* \< 0.001 versus normal group](IJPVM-9-30-g004){#F4}

Discussion {#sec1-4}
==========

Dex as a potent synthetic glucocorticoid is identified to cause hyperlipidemia through various mechanisms including decreased activity of lipoprotein lipase and increased secretion of very low-density lipoprotein (VLDL) by the liver, increased hepatic lipogenesis and accumulation of triglyceride within the liver, enhanced VLDL formation by intestine, decreased activity of lecithin cholesterol acetyl transferase and increased free cholesterol level, increased lipolysis in adipose tissue, and increased circulating fatty acids.\[[@ref17][@ref18][@ref19]\] Moreover, high level of glucocorticoids are associated with insulin resistance, hyperinsulinemia, and hyperglycemia which are also linked to dyslipidemia.\[[@ref20]\] Dex-induced hyperlipidemia is related with overproduction of reactive oxygen species (ROS) and oxidative damage in several tissues such as liver.\[[@ref21]\]

In this study, treatment with almost all fractions of *T. polium* significantly reduced the level of serum lipid markers and increased the serum level of HDL. However, there was a striking elevation in hepatic marker enzymes.

Among different fractions, chloroform fraction appeared to be more potent in hypolipidemic activity in a dose-dependent manner. It was comparable with atorvastatin (40 mg/kg) at the lower dose of 50 mg/kg. Aqueous fraction has also good antihyperlipidemic activity, but there was less hypolipidemic activity for butanol fraction.

Previous studies have reported hypolipidemic effect for *T. polium*. Rasekh *et al*. showed 29%--46% reduction in total cholesterol and 34% reduction in triglyceride level by administration of *T. polium* water extract in an animal model of hyperlipidemia which was induced by administration of streptozotocin with high fat diet.\[[@ref13]\] In the study of Vahidi *et al*., the boiled aqueous extract of *T. polium* reduced serum glucose and triglyceride in diabetic rats but had no effect on cholesterol level.\[[@ref14]\] In spite of strong hypoglycemic activity, Shahraki *et al*. have reported no hypolipidemic effect for aqueous extract of *T. polium* in diabetic rats.\[[@ref22]\] This inconsistency in the results may be due to the dissimilarity in method of administration of *T. polium* extract.

*T. polium* is considered as a source of bioactive chemical materials with potential pharmacological activity. Phytochemically, chloroform fraction is rich in terpenoids including abeo-abietane and neo-clerodane diterepenes, sesquiterpenes from eudesmane and germacrane types.\[[@ref23][@ref24]\] Aqueous fraction contains polyphenolic compounds, and butanol fraction is rich in iridoids, phenyl ethanols, and flavonoids,\[[@ref25][@ref26]\] which could be considered as probable active constituents. However, further studies are needed to determine possible mechanisms of action of each constituent for the management of hyperlipidemia.

Unfortunately, despite strong hypolipidemic activity, hepatotoxic effect was observed for all fractions of *T. polium* mainly for chloroform fraction. Highly elevation of ALT and AST enzymes may be related to neo-clerodane diterpenes, especially teucrin A and teuchamaedryn A in this fraction. Their furan and hydrofuran rings polyoxidized by CYP3A4 and produced ROS responsible for liver damages.\[[@ref27]\] It is important to mention that several forms of liver injury have been reported, especially in the high dose of glucocorticoids administration. Oxidative damage and growth retardation may be participating in the effect of corticosteroids therapy on the liver function.\[[@ref21][@ref28]\]

Conclusions {#sec1-5}
===========

In conclusion, this study showed strong hypolipidemic effect of chloroform, butanol, and aqueous fractions of hydroalcoholic extract of *T. polium* in an animal model of hyperlipidemia. Chloroform and aqueous fractions may be potential candidates for isolation of bioactive antihyperlipidemic constituents; however, identification and separation of hepatotoxic compounds and taking low doses should be considered for clinical application.
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